Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Neuroscience

Research Field

Building up to a breakthrough

| Jonathan James

We sat down with David Eidelberg shortly after the publication of his group’s most recent paper in Science Translational Medicine.

Disease Area

A Neural Precedent

| Jonathan James

Interneuron activity suggests that there’s more to the story of seizure onset

Disease Area

Brain Network Manipulation

| Jonathan James

Cutting-edge imaging, predictive modeling and gene therapy combine for a new direction in neurodegenerative disease research

Research Field

The Power To Change Lives

| Stephanie Sutton

Sitting Down With… Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland.

Research Field

Not Immune to Damage

| Ruth Steer

Could activated T cells play a major role in driving neurodegeneration in glaucoma?

Research Field

Better Biomarkers for AD R&D

| Carlo Medici

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging, even if blood screening tests become a reality

Research Field

The Pitter-Patter of Tiny Diagnoses

A simple yet accurate model could help streamline ROP screening

Research Field

The Matchmaker

| Paul Ursell

Introducing the easy-to-use system that offers patients lower risks of complications – regardless of surgeon experience

Research Field

Searching for Schizophrenia

| Michael Schubert

Researchers identified the cell types associated with schizophrenia mutations

Research Field

Bringing Alzheimer’s in from the Cold

| Roisin McGuigan

With big pharma seemingly pulling out of the field, what hope remains for novel treatments for Alzheimer’s disease?


Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register